Silibinin causes apoptosis and cell cycle arrest in some human pancreatic cancer cells

International Journal of Molecular Sciences

Volumn 12, Issue 8, 2011, Pages 4861-4871

  Ge, Yakun ^a,b   Zhang, Yuanxin ^a,b   Chen, Yunpeng ^a   Li, Quanshun ^a   Chen, Jun ^c   Dong, Ying ^c   Shi, Wei ^a  

^a JILIN UNIVERSITY   (China)

^b JILIN INSTITUTE OF CHEMICAL TECHNOLOGY   (China)

^c JIANGSU UNIVERSITY   (China)

Author keywords

Apoptosis; Cell proliferation; Cell cycle arrest; Pancreatic cancer; Silibinin

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; SILIBININ; ANTINEOPLASTIC AGENT; CASPASE; SILYMARIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PANCREAS CANCER; CELL CYCLE CHECKPOINT; DRUG EFFECTS; METABOLISM; PANCREAS TUMOR; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; HUMANS; PANCREATIC NEOPLASMS; SILYMARIN;

EID: 80052165455     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12084861     Document Type: Article

References (22)

1. Duan, W.J.; Li, Q.S.; Xia, M.Y.; Tashiro, S.; Onodera, S.; Ikejima, T. Silibinin activated p53 and induced autophagic death in human fibrosarcoma HT1080 cells via reactive oxygen species-p38 and c-Jun N-terminal kinase pathways. Biol. Pharm. Bull. 2011, 34, 47-53.
2. Deep, G.; Agarwal, R. Antimetastatic efficacy of Silibinin: Molecular mechanisms and therapeutic potential against cancer. Cancer Metast. Rev. 2010, 29, 447-463.
3. Hahn, V.G.; Lehmann, H.D.; Kürten, M.; Uebel, H.; Vogel, G. Pharmacology and toxicology of silymarin antihepatotoxic agent of Silybum marianum (L) gaertn. Arzneim.-Forsch.-Drug Res. 1968, 18, 698-704.
4. Vogel, G.; Trost, W.; Braatz, R.; Odenthal, K.P.; Brüsewitz, G.; Antweiler, H.; Seeger, R. Pharmacodynamics, site and mechanism of action of silymarin, the antihepatoxic principle from Silybum mar. (L) Gaertn. 1. Acute toxicology or tolerance, general and specific (liver-) pharmacology. Arzneim.-Forsch.-Drug Res. 1975, 25, 82-89.
5. Flora, K.; Hahn, M.; Rosen, H.; Benner, K. Milk thistle (Silybum marianum) for the therapy of liver disease. Am. J. Gastroenterol. 1998, 93, 139-143.
6. Wellington, K.; Jarvis, B. Silymarin: A review of its clinical properties in the management of hepatic disorders. Biodrugs 2001, 15, 465-489.
7. Kim, H.O.; Choi, H.K.; Ha, E.S.; Lee, K.J.; Hur, G.Y.; Jung, K.H.; Lee, S.Y.; Lee, S.Y.; Kim, J.H.; Shin, C.; et al. Silibinin induces apoptosis by downregulating survivin through inhibition of hypoxia-inducible factor-1 alpha in non-small cell lung cancer cells. J. Thorac. Oncol. 2010, 5, S248.
8. Tyagi, A.; Singh, R.P.; Agarwal, C.; Agarwal, R. Silibinin activates p53-caspase 2 pathway and causes caspase-mediated cleavage of Cip1/p21 in apoptosis induction in bladder transitional-cell papilloma RT4 cells: Evidence for a regulatory loop between p53 and caspase 2. Carcinogenesis 2006, 27, 2269-2280.
9. Agarwal, C.; Singh, R.P.; Dhanalakshmi, S.; Tyagi, A.K.; Tecklenburg, M.; Sclafani, R.A.; Agarwal, R. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 2003, 22, 8271-8282.
10. Jemal, A.; Siegel, R.; Xu, J.Q.; Ward, E. Cancer Statistics, 2010. CA Cancer J. Clin. 2010, 60, 277-300.
11. Park, Y.J.; Wen, J.; Bang, S.; Park, S.W.; Song, S.Y. [6]-Gingerol induces cell cycle arrest and cell death of mutant p53-expressing pancreatic cancer cells. Yonsei Med. J. 2006, 47, 688-697.
12. Lowe, S.W.; Lin, A.W. Apoptosis in cancer. Carcinogenesis 2000, 21, 485-495.
13. Petak, I.; Houghton, J.A. Shared pathways: Death receptors and cytotoxic drugs in cancer therapy. Pathol. Oncol. Res. 2001, 7, 95-106.
14. Debatin, K.M.; Poncet, D.; Kroemer, G. Chemotherapy: Targeting the mitochondrial cell death pathway. Oncogene 2002, 21, 8786-8803.
15. Irene, M.; Thomas, E.; Alex, A. Targeting apoptosis Pathways in Cancer Therapy. CA Cancer J. Clin. 2005, 55, 178-194.
16. Tyagi, A.; Agarwal, C.; Harrison, G.; Glode, L.M.; Agarwal, R. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages. Carcinogenesis 2004, 25, 1711-1720.
17. Hogan, F.S.; Krishnegowda, N.K.; Mikhailova, M.; Kahlenberg, M.S. Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer. J. Surg. Res. 2007, 143, 58-65.
18. Deep, G.; Singh, R.P.; Agarwal, C.; Kroll, D.J.; Agarwal, R. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: A comparison of flavanone silibinin with flavanolignan mixture silymarin. Oncogene 2006, 25, 1053-1069.
19. Mateen, S.; Tyagi, A.; 1, Agarwal, C.; Singh, R.P.; Agarwal, R. Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators. Mol. Carcinog. 2010, 49, 247-258.
20. Agarwal, C.; Singh, R.P.; Dhanalakshmi, S.; Tyagi, A.K.; Tecklenburg, M.; Sclafani, R.A.; Agarwal, R. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 2003, 22, 8271-8282.
21. Li, L.; Gao, Y.; Zhang, L.; Zeng, J.; He, D.; Sun, Y. Silibinin inhibits cell growth and induces apoptosis by caspase activation, down-regulating survivin and blocking EGFR-ERK activation in renal cell carcinoma. Cancer Lett. 2008, 272, 61-69.
22. Wesierska-Gadek, J.; Gueorguieva, M.; Horky, M. Dual action of cyclin-dependent kinase inhibitors: induction of cell cycle arrest and apoptosis. A comparison of the effects exerted by roscovitine and cisplatin. Pol. J. Pharmacol. 2003, 55, 895-902.